Epilepsy in women of reproductive age

Cover Page

Cite item

Full Text


Four hundred fourty seven women with epilepsy aged 18–55 years were examineds, and catamenial epilepsy (CE) and/or reproductive dysfunction was diagnosed in 64 cases. Methods of investigation included clinical and neurological examination, routine EEG and/or video-EEG-monitoring, brain MRI, and laboratory tests. In the examined patients, antiepileptic drugs (AED) were prescribed for the first time or current therapy was corrected. CE was diagnosed in 30 cases: a perimenstrual form of CE was revealed in 24 cases, a luteal phase form in 5, and an ovulation form in one. Idiopathic generalized epilepsy (IGE) was diagnosed in 2 cases, temporal lobe epilepsy in 20, frontal epilepsy in 6, and non-localized focal epilepsy in 2. High frequency of seizures correlated with inefficacy of treatment (r = 0.3; p <0.05). Menstrual cycle (MC) dysfunction was diagnosed in 25 cases: dysmenorrhea in 21 and amenorrhea in 4. MC dysfunction was associated with excess weight in 44% of cases, and with ovarian cysts or polycystic ovary syndrome in 20%. After correction of the treatment, normalization of MC was achieved in 48% of cases. In this group, remission was observed in 57.1% of cases, improvement in 14.3%, and the lack of effect in 28.6%. Some correlations of the AED efficiency with positive dynamics of MC were shown.


About the authors

A. S. Kotov

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Author for correspondence.
Email: alex-013@yandex.ru
Russian Federation, Moscow


  1. Backström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 1976; 54: 321–347.
  2. Bauer J., Jarre A., Klingmuller M. et al. Polycystic ovary syndrome in patients with focal epilepsy: A study in 93 women. Epilepsy Res. 2000; 41(2): 163–167.
  3. Bilo L., Meo R., Valentino R. et al. Characterization of reproductive endocrine disorders in women with epilepsy. J. Clin. Endocrinol. Metab. 2001; 86(7): 2950–2956.
  4. Fawley J.A., Pouliot W.A., Dudek F.E. Epilepsy and reproductive disorders: The role of the gonadotropin-releasing hormone network. Epilepsy Behav. 2006; 8: 477–482.
  5. Frye C.A., Bayon L.E. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha, 5 alpha THP. Neuroendocrinology 1998; 68: 272–280.
  6. Harden C.L. Polycystic ovaries and polycystic ovary syndrome in epilepsy: Evidence for neurogonadal disease. Epilepsy Curr. 2005; 5: 142–146.
  7. Harden C.L., Pulver M.C., Ravdin L. et al. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40: 1402–1407.
  8. Herzog A.G. Altered reproductive endocrine regulation in men with epilepsy: Implications for reproductive function and seizures. Ann Neurol. 2002; 51: 539–542.
  9. Hsu F.C., Smith S.S. Progesterone withdrawal reduces paired-pulse inhibition in rat hippocampus: Dependence on GABA(A) receptor alpha4 subunit upregulation. J. Neurophysiol. 2003; 89: 186–198.
  10. Murialdo G., Galimberti C.A., Fonzi S. et al. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality. Epilepsia 1995; 36: 360–365.
  11. Reddy D.S., Kim H.Y., Rogawski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 2001; 42: 328–336.

Supplementary files

Supplementary Files

Copyright (c) 2010 Kotov A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies